학술논문
Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia
Document Type
Article
Author
Kadia, T.M.; Ravandi, F.; Molica, M.; Bataller, A.; Borthakur, G.; Daver, N.; Jabbour, E.; DiNardo, C.D.; Pemmaraju, N.; Jain, N.; Ferrajoli, A.; Ylimaz, M.; Bose, P.; Islam, R.; Konopleva, M.; Garcia-Manero, G.; Kantarjian, H.; Tidwell, R.S.; Marx, K.R.; Rausch, C.R.; Kanagal-Shamanna, R.; Wang, S.; Champlin, R.; Shpall, E.
Source
In: American Journal of Hematology . (American Journal of Hematology, November 2023, 98(11):1711-1720)
Subject
Language
English
ISSN
10968652
03618609
03618609